Continuus Pharma to build $125M manufacturing site in Massachusetts
Continuus Pharma to build $125M manufacturing site in Massachusetts jkeenan [...]
Novo Holdings buys sterile injectables maker Ritedose for undisclosed price
Novo Holdings buys sterile injectables maker Ritedose for undisclosed price [...]
Arcutis reups ahead of critical year for topical drug delivery tech, securing $225M debt financing to fund product launch, pivotal readouts
Arcutis reups ahead of critical year for topical drug delivery [...]
Xeris Biopharma scores FDA approval for endogenous Cushing’s syndrome drug Recorlev
Xeris Biopharma scores FDA approval for endogenous Cushing’s syndrome drug [...]
Teva suffers trial loss in New York’s landmark opioid case
Teva suffers trial loss in New York’s landmark opioid case [...]
To buy or not to buy? Samsung unit denies report about Biogen talks
To buy or not to buy? Samsung unit denies report [...]
Biogen’s rollercoaster 2021 takes another surprising turn with report of $42B Samsung buyout interest
Biogen’s rollercoaster 2021 takes another surprising turn with report of [...]
Biogen’s roller coaster 2021 takes another surprising turn with report of $42B Samsung buyout interest
Biogen’s roller coaster 2021 takes another surprising turn with report [...]
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs [...]
Leo Pharma gains FDA nod for eczema drug Adbry, but can it challenge Sanofi and Regeneron’s formidable Dupixent?
Leo Pharma gains FDA nod for eczema drug Adbry, but [...]